201 related articles for article (PubMed ID: 32200817)
1. A Prospective, Randomized, Double-blind, Placebo-controlled Study of Orbital Radiotherapy for Graves' Ophthalmopathy.
Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
Ophthalmology; 2020 Apr; 127(4S):S160-S171. PubMed ID: 32200817
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy.
Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
Ophthalmology; 2001 Sep; 108(9):1523-34. PubMed ID: 11535445
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for Graves' ophthalmopathy: results at one year.
Gorman CA
Thyroid; 2002 Mar; 12(3):251-5. PubMed ID: 11952049
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
[TBL] [Abstract][Full Text] [Related]
5. The aftermath of orbital radiotherapy for graves' ophthalmopathy.
Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Buettner H; Robertson DM; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
Ophthalmology; 2002 Nov; 109(11):2100-7. PubMed ID: 12414422
[TBL] [Abstract][Full Text] [Related]
6. Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology.
Bradley EA; Gower EW; Bradley DJ; Meyer DR; Cahill KV; Custer PL; Holck DE; Woog JJ
Ophthalmology; 2008 Feb; 115(2):398-409. PubMed ID: 18082885
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of extraocular muscle volume and exophthalmos reduction after radiation therapy to treat Graves' ophthalmopathy: A pilot study.
Kim M; Chang JH; Lee NK
Eur J Ophthalmol; 2021 Mar; 31(2):340-345. PubMed ID: 31496266
[TBL] [Abstract][Full Text] [Related]
8. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Systemic Steroids and Orbital Radiation for Active Graves Orbitopathy on Postdecompression Extraocular Muscle Volume.
Kim JW; Lee KH; Woo YJ; Kim J; Keum KC; Yoon JS
Am J Ophthalmol; 2016 Nov; 171():11-17. PubMed ID: 27542927
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in the radiotherapy of Graves' ophthalmopathy.
Petersen IA; Kriss JP; McDougall IR; Donaldson SS
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):259-64. PubMed ID: 2118493
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy.
Stan MN; Garrity JA; Bradley EA; Woog JJ; Bahn MM; Brennan MD; Bryant SC; Achenbach SJ; Bahn RS
J Clin Endocrinol Metab; 2006 Dec; 91(12):4817-24. PubMed ID: 16984988
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of graves' ophthalmopathy treated with intensity modulated radiation therapy.
Li YJ; Luo Y; He WM; Li P; Wang F
Radiat Oncol; 2017 Nov; 12(1):171. PubMed ID: 29110673
[TBL] [Abstract][Full Text] [Related]
14. Extraocular muscle repositioning as the last therapeutic option for a patient with a severe course of Graves' Ophthalmopathy: a case report.
Rau A; Klopfer M; Rommel N; Rau-Fornefeld M; Kolk A
BMC Ophthalmol; 2018 Feb; 18(1):56. PubMed ID: 29482520
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of endoscopic orbital decompression for graves' ophthalmopathy.
Woods RSR; Pilson Q; Kharytaniuk N; Cassidy L; Khan R; Timon CVI
Ir J Med Sci; 2020 Feb; 189(1):177-183. PubMed ID: 31203506
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Graves' ophthalmopathy by steroid therapy, orbital radiation therapy, plasmapheresis and thyroxine replacement.
Yamamoto K; Saito K; Takai T; Yoshida S
Endocrinol Jpn; 1982 Aug; 29(4):495-501. PubMed ID: 6897533
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and Side Effects of Lateral Orbital Wall Decompression Including the Orbital Rim in Patients with Graves' Orbitopathy].
Horn M; Schittkowski MP
Klin Monbl Augenheilkd; 2019 Jan; 236(1):17-24. PubMed ID: 30690696
[TBL] [Abstract][Full Text] [Related]
18. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
Nagy EV; Toth J; Kaldi I; Damjanovich J; Mezosi E; Lenkey A; Toth L; Szabo J; Karanyi Z; Leovey A
Eur J Endocrinol; 2000 Jun; 142(6):591-7. PubMed ID: 10832104
[TBL] [Abstract][Full Text] [Related]
19. Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy.
Choi SW; Lee JY; Lew H
Korean J Ophthalmol; 2016 Feb; 30(1):1-9. PubMed ID: 26865797
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of rituximab in patients with Graves' orbitopathy.
Stan MN; Garrity JA; Carranza Leon BG; Prabin T; Bradley EA; Bahn RS
J Clin Endocrinol Metab; 2015 Feb; 100(2):432-41. PubMed ID: 25343233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
